price

NASDAQ · OCUL
Ocular Therapeutix, Inc.
Healthcare · Biotechnology
$6.97
Down-$0.34 (-4.65%)
Updated Nov 1, 2026, 5:59 PM
SID Score
4.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $6.00 – $16.44
- Volume
- 2.63M
- Avg. volume
- 3.15M
Price performance · OCUL
OCUL price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
OCUL closed at $6.97 after 20 trading sessions, down 3.86% for the selected period.
- Last close
- $6.97
- Period change
- -3.86%
- Period low
- $6.29
- Period high
- $7.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $7.27 | $7.38 | $6.92 | $6.97 | 2.63M |
| Oct 29, 2026 | $7.36 | $7.535 | $7.29 | $7.31 | 2.21M |
| Oct 28, 2026 | $6.68 | $7.34 | $6.60 | $7.29 | 2.85M |
| Oct 27, 2026 | $6.48 | $6.75 | $6.42 | $6.72 | 2.22M |
| Oct 26, 2026 | $6.50 | $6.62 | $6.40 | $6.47 | 1.69M |
| Oct 23, 2026 | $6.68 | $6.68 | $6.345 | $6.50 | 1.86M |
| Oct 22, 2026 | $6.42 | $6.665 | $6.395 | $6.61 | 2.15M |
| Oct 21, 2026 | $6.69 | $6.7499 | $6.375 | $6.48 | 2.49M |
| Oct 20, 2026 | $6.30 | $6.775 | $6.30 | $6.65 | 2.62M |
| Oct 19, 2026 | $7.13 | $7.18 | $6.00 | $6.29 | 8.36M |
| Oct 16, 2026 | $7.38 | $7.39 | $6.85 | $6.87 | 2.76M |
| Oct 15, 2026 | $7.29 | $7.465 | $7.23 | $7.38 | 3.25M |
| Oct 14, 2026 | $7.14 | $7.30 | $7.07 | $7.20 | 2.21M |
| Oct 13, 2026 | $7.55 | $7.61 | $7.20 | $7.24 | 3.22M |
| Oct 12, 2026 | $7.60 | $7.75 | $7.36 | $7.56 | 3.67M |
| Oct 9, 2026 | $7.49 | $7.68 | $7.38 | $7.54 | 2.63M |
| Oct 8, 2026 | $7.20 | $7.565 | $7.06 | $7.51 | 3.9M |
| Oct 7, 2026 | $7.26 | $7.545 | $7.19 | $7.23 | 2.93M |
| Oct 6, 2026 | $7.30 | $7.565 | $7.13 | $7.34 | 2.81M |
| Oct 5, 2026 | $6.93 | $7.27 | $6.79 | $7.25 | 5.62M |
Latest OCUL news
The latest Smart Investors Daily articles mentioning OCUL.
Stock researchCompany · Earnings
Company
Market Activity
Research & News
Loading stock research…

